Rechercher

Pages

1. • Article de périodique

   • 

   Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA.

   Liénard, Danielle Rimoldi, Donata Marchand, Marie Dietrich, Pierre-Yves van Baren, Nicolas[UCL] Geldhof, Christine Batard, Pascal Guillaume, Philippe Ayyoub, Maha Pittet, Mikaël J Zippelius, Alfred Fleischhauer, Katharina Lejeune, Ferdy Cerottini, Jean-Charles Romero, Pedro Speiser, Daniel E (2004) Cancer Immunity — Vol. 4, p. 4 (2004)
2. • Article de périodique

   • 

   Plasma cells in primary melanoma. Prognostic significance and possible role of IgA.

   Bosisio, Francesca M Wilmott, James S Volders, Nathalie Mercier, Marjorie[UCL] Wouters, Jasper Stas, Marguerite Blokx, Willeke Am Massi, Daniela Thompson, John F Scolyer, Richard A van Baren, Nicolas[UCL] van den Oord, Joost J (2016) Modern Pathology — Vol. 29, no. 4, p. 347-358 (2016)
3. • Chapitre

   • 

   Improving the clinical efficacy of cancer vaccines by targeting immune suppression in human tumors

   Demotte, Nathalie[UCL] Antonopoulos, Aristotelis Baurain, Jean-François[UCL] Wieers, Grégoire[UCL] van Baren, Nicolas[UCL] van der Bruggen, Pierre[UCL] (2012) Galectins and Disease Implications for Targeted Therapeutics. Proceedings of the First Symposium on Galectin-Related Therapeutics — [ISBN : 978-0-8412-2880-1]
4. • Article de périodique

   • 

   Defining the prognostic value for galectin-3 in cutaneous melanoma.

   Vereecken, P Ghanem, G Morandini, R Suciu, S van Baren, Nicolas[UCL] Heenen, M (2007) The Journal of International Medical Research — Vol. 35, no. 5, p. 731-732 (2007)
5. • Communication

   • 

   Monitoring CTL responses in cancer patients vaccinated with a tumor-specific antigen.

   van Baren, Nicolas[UCL] (2008) Meeting of the International Society for Cellular Therapy — Antwerp
6. • Communication

   • 

   Invited Lecture: Where do we go with peptides in cancer vaccines ?

   van Baren, Nicolas[UCL] Baurain, Jean-François[UCL] (2008) 2d meeting of the Cancerimmunotherapy Consortium — Brussels (Belgium)
7. • Communication

   • 

   Invited Lecture: Achievements with immunotherapy of cancers.

   van Baren, Nicolas[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1999) Eurocancer 99 — Paris (France)
8. • Communication

   • 

   Immunotherapy of cancer. Where are we ?

   van Baren, Nicolas[UCL] (2009) 24th meeting of the Belgian Hematological Society — Oostende (Belgium)
9. • Article de périodique

   • 

   Tryptophan-degrading enzymes in tumoral immune resistance

   van Baren, Nicolas[UCL] Van den Eynde, Benoît[UCL] (2015) Frontiers in Immunology — Vol. 6, no. 34, p. 1-9 (03/02/2015)
10. • Article de périodique

    • 

    Tumoral immune resistance mediated by enzymes that degrade tryptophan

    Van den Eynde, Benoît[UCL] van Baren, Nicolas[UCL] (2015) Cancer Immunology Research — (2015)
11. • Article de périodique

    • 

    Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance

    Vigneron, Nathalie[UCL] van Baren, Nicolas[UCL] Van den Eynde, Benoît[UCL] (2015) OncoImmunology — Vol. 4, no. 5, p. e1003012 (2015)
12. • Article de périodique

    • 

    Highly Aggressive Metastatic Melanoma Cells Unable to Maintain Telomere Length.

    Viceconte, Nikenza[UCL] Dheur, Marie-Sophie[UCL] Majerova, Eva[UCL] Pierreux, Christophe[UCL] Baurain, Jean-François[UCL] van Baren, Nicolas[UCL] Decottignies, Anabelle[UCL] (2017) Cell Reports — Vol. 19, no. 12, p. 2529-2543 (2017)
13. • Article de périodique

    • 

    MAGE-A genes are not expressed in human leukemias.

    Chambost, H van Baren, Nicolas[UCL] Brasseur, Francis[UCL] Olive, D (2001) Leukemia — Vol. 15, no. 11, p. 1769-1771 (2001)
14. • Article de périodique

    • 

    A synopsis of serum biomarkers in cutaneous melanoma patients

    Vereecken, Pierre[UCL] Cornelis, Frank[UCL] van Baren, Nicolas[UCL] Vandersleyen, Valérie[UCL] Baurain, Jean-François[UCL] (2012) Dermatology Research and Practice — Vol. 2012, p. 260643 [1-7] (2012)
15. • Article de périodique

    • 

    Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.

    Shi, Hubing Hugo, Willy Kong, Xiangju Hong, Aayoung Koya, Richard C Moriceau, Gatien Chodon, Thinle Guo, Rongqing Johnson, Douglas B Dahlman, Kimberly B Kelley, Mark C Kefford, Richard F Chmielowski, Bartosz Glaspy, John A Sosman, Jeffrey A van Baren, Nicolas[UCL] Long, Georgina V Ribas, Antoni Lo, Roger S (2014) Cancer Discovery — Vol. 4, no. 1, p. 80-93 (2014)
16. • Communication

    • 

    Vaccination anti-tumorale.

    van Baren, Nicolas[UCL] (2009) Cinquièmes journées d'immunologie et immunothérapie des cancers. — Dijon (France)
17. • Article de périodique

    • 

    Von Recklinghausen neurofibromatosis and hematologic malignancies : 2 case reports in adulthood.

    van Baren, Nicolas[UCL] Issa , A Delannoy, André (1992) Acta Clinica Belgica — Vol. 48, no.3, p. 164-170 (1992)
18. • Communication

    • 

    Clinical and immunological effects of various vaccines based on defined tumor antigens.

    van Baren, Nicolas[UCL] Baurain, Jean-François[UCL] (2007) 6th Meeting of the Theravac Consortium — Paris (France)
19. • Communication

    • 

    Invited Lecture: Vaccination of melanoma patients with MAGE peptides.

    van Baren, Nicolas[UCL] Marchand, Marie[UCL] Weynants, Patrick[UCL] (1998) European Association for Cancer Research, XVth Meeting — Stockholm (Sweden)
20. • Article de périodique

    • 

    A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors.

    Loriot, Axelle Van Tongelen, Aurélie Blanco, Jordi Klaessens, Simon Cannuyer, Julie van Baren, Nicolas Decottignies, Anabelle De Smet, Charles (2014) Epigenetics — Vol. 9, no. 8, p. 1163-1171 (2014)
21. • Communication

    • 

    Translational research in melanoma: Anti-tumoral immunity at work in melanoma metastases.

    van Baren, Nicolas[UCL] (2012) EUMeet Brussels — Brussels
22. • Article de périodique

    • 

    Intoxication professionnelle a l'aniline par voie percutanée : présentation d'un cas

    van Baren, Nicolas[UCL] Goossens, E. Mostin, M. (1992) Reanimation - Urgences — Vol. 1, no.6, p. 963-965 (1992)
23. • Article de périodique

    • 

    Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.

    Benitez, R Godelaine, Danièle[UCL] Lopez-Nevot, M A Brasseur, F Jiménez, P Marchand, M Oliva, M R van Baren, Nicolas[UCL] Cabrera, T Andry, G Landry, C Ruiz-Cabello, F Boon, Thierry[UCL] Garrido, F (1998) Tissue Antigens — Vol. 52, no.6, p. 520-9 (1998)
24. • Communication

    • 

    Neogenesis of lymphoid structures in metastatic melanoma.

    van Baren, Nicolas[UCL] (2012) NIBIT (Italian Network for Tumor Biotherapy) 10th Annual Meeting — Siena (Italy)
25. • Communication

    • 

    Invited Lecture: Clinical and immunological effects in melanoma patients vaccinated with MAGE antigens.

    van Baren, Nicolas[UCL] (2006) The Second International Cancer Vaccine Meeting. — Borgo San Luigi, Monteriggioni (Siena, Italy)

Pages